Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:15988245rdf:typepubmed:Citationlld:pubmed
pubmed-article:15988245lifeskim:mentionsumls-concept:C0008976lld:lifeskim
pubmed-article:15988245lifeskim:mentionsumls-concept:C0006055lld:lifeskim
pubmed-article:15988245lifeskim:mentionsumls-concept:C0015462lld:lifeskim
pubmed-article:15988245lifeskim:mentionsumls-concept:C0027756lld:lifeskim
pubmed-article:15988245lifeskim:mentionsumls-concept:C0439655lld:lifeskim
pubmed-article:15988245lifeskim:mentionsumls-concept:C2349179lld:lifeskim
pubmed-article:15988245pubmed:issue1lld:pubmed
pubmed-article:15988245pubmed:dateCreated2005-6-30lld:pubmed
pubmed-article:15988245pubmed:abstractTextAberrant facial nerve regeneration syndrome is systematically studied by constructing a subjective questionnaire organized into pertinent domains (impairment of quality of life, social interactions, perception of self-appearance, visual function, and perception of problem severity) and by physical assessment of degree of involuntary palpebral fissure closure during routine facial movements using videotaping and a physicians' grading scale.lld:pubmed
pubmed-article:15988245pubmed:languageenglld:pubmed
pubmed-article:15988245pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15988245pubmed:citationSubsetAIMlld:pubmed
pubmed-article:15988245pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15988245pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15988245pubmed:statusMEDLINElld:pubmed
pubmed-article:15988245pubmed:monthJullld:pubmed
pubmed-article:15988245pubmed:issn1529-4242lld:pubmed
pubmed-article:15988245pubmed:authorpubmed-author:SlatteryWilli...lld:pubmed
pubmed-article:15988245pubmed:authorpubmed-author:JohnsonEricElld:pubmed
pubmed-article:15988245pubmed:authorpubmed-author:GoodnoughMich...lld:pubmed
pubmed-article:15988245pubmed:authorpubmed-author:McKennaMichae...lld:pubmed
pubmed-article:15988245pubmed:authorpubmed-author:BorodicGaryGlld:pubmed
pubmed-article:15988245pubmed:authorpubmed-author:BartleyMaryMlld:pubmed
pubmed-article:15988245pubmed:authorpubmed-author:GlasscockMich...lld:pubmed
pubmed-article:15988245pubmed:authorpubmed-author:MalazioCarlClld:pubmed
pubmed-article:15988245pubmed:authorpubmed-author:AcquadroMarti...lld:pubmed
pubmed-article:15988245pubmed:issnTypeElectroniclld:pubmed
pubmed-article:15988245pubmed:volume116lld:pubmed
pubmed-article:15988245pubmed:ownerNLMlld:pubmed
pubmed-article:15988245pubmed:authorsCompleteYlld:pubmed
pubmed-article:15988245pubmed:pagination36-43lld:pubmed
pubmed-article:15988245pubmed:dateRevised2011-2-16lld:pubmed
pubmed-article:15988245pubmed:meshHeadingpubmed-meshheading:15988245...lld:pubmed
pubmed-article:15988245pubmed:meshHeadingpubmed-meshheading:15988245...lld:pubmed
pubmed-article:15988245pubmed:meshHeadingpubmed-meshheading:15988245...lld:pubmed
pubmed-article:15988245pubmed:meshHeadingpubmed-meshheading:15988245...lld:pubmed
pubmed-article:15988245pubmed:meshHeadingpubmed-meshheading:15988245...lld:pubmed
pubmed-article:15988245pubmed:meshHeadingpubmed-meshheading:15988245...lld:pubmed
pubmed-article:15988245pubmed:meshHeadingpubmed-meshheading:15988245...lld:pubmed
pubmed-article:15988245pubmed:meshHeadingpubmed-meshheading:15988245...lld:pubmed
pubmed-article:15988245pubmed:meshHeadingpubmed-meshheading:15988245...lld:pubmed
pubmed-article:15988245pubmed:meshHeadingpubmed-meshheading:15988245...lld:pubmed
pubmed-article:15988245pubmed:meshHeadingpubmed-meshheading:15988245...lld:pubmed
pubmed-article:15988245pubmed:meshHeadingpubmed-meshheading:15988245...lld:pubmed
pubmed-article:15988245pubmed:meshHeadingpubmed-meshheading:15988245...lld:pubmed
pubmed-article:15988245pubmed:meshHeadingpubmed-meshheading:15988245...lld:pubmed
pubmed-article:15988245pubmed:meshHeadingpubmed-meshheading:15988245...lld:pubmed
pubmed-article:15988245pubmed:meshHeadingpubmed-meshheading:15988245...lld:pubmed
pubmed-article:15988245pubmed:meshHeadingpubmed-meshheading:15988245...lld:pubmed
pubmed-article:15988245pubmed:meshHeadingpubmed-meshheading:15988245...lld:pubmed
pubmed-article:15988245pubmed:year2005lld:pubmed
pubmed-article:15988245pubmed:articleTitleBotulinum toxin for aberrant facial nerve regeneration: double-blind, placebo-controlled trial using subjective endpoints.lld:pubmed
pubmed-article:15988245pubmed:affiliationMassachusetts Eye and Ear Infirmary, Boston, Massachusetts, USA.lld:pubmed
pubmed-article:15988245pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:15988245pubmed:publicationTypeClinical Triallld:pubmed
pubmed-article:15988245pubmed:publicationTypeMulticenter Studylld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15988245lld:pubmed